Parkinson's Disease
|
OPPORTUNITY NUMBER |
OPPORTUNITY TITLE |
AGENCY NAME |
POSTED DATE |
CLOSE DATE |
|---|---|---|---|---|
|
NINDS Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50 Clinical Trial Optional) |
HHS-NIH11 |
07/15/2020 |
09/26/2022 |
|
|
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21- Clinical Trial Not Allowed) |
NIH |
01/14/2020 |
04/01/2022 |
|
|
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01- Clinical Trial Not Allowed) |
NIH |
01/14/2020 |
04/01/2022 |
|
|
Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed) |
NIH |
01/03/2020 |
01/07/2023 |
|
|
Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed) |
NIH |
01/03/2020 |
01/07/2023 |
|
|
BRAIN Initiative: Biology and Biophysics of Neural Stimulation and Recording Technologies (R01 Clinical Trials Optional) |
NIH |
01/02/2020 |
10/03/2022 |
|
|
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) |
NIH |
12/09/2019 |
09/07/2022 |
|
|
NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) |
NIH |
11/22/2019 |
01/07/2023 |
|
|
NIDCR Research Grants for Analyses of Existing Genomics Data (R01 Clinical Trial Not Allowed) |
NIH |
11/08/2019 |
01/07/2023 |
|
|
Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed) |
NIH |
09/10/2019 |
11/08/2022 |
|
|
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed) |
NIH |
09/09/2019 |
05/07/2021 |
|
|
Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed) |
NIH |
09/09/2019 |
08/11/2021 |
|
|
Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) |
NIH |
09/09/2019 |
08/11/2021 |
|
|
Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) |
NIH |
09/09/2019 |
08/11/2021 |
|
|
Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed) |
NIH |
09/09/2019 |
08/11/2021 |
|
|
Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed) |
NIH |
09/09/2019 |
08/11/2021 |
|
|
Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) |
NIH |
09/09/2019 |
09/07/2022 |
|
|
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinical Trial Not Allowed) |
NIH |
08/16/2019 |
07/16/2022 |
|
|
Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 Clinical Trial Not Allowed) |
NIH |
06/28/2019 |
01/14/2022 |
|
|
Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R21/R33 Clinical Trial Optional) |
NIH |
06/25/2019 |
07/16/2022 |
|
|
Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R33 Clinical Trial Optional) |
NIH |
06/25/2019 |
07/16/2022 |
|
|
Progression Markers for Cognitive Impairment in Parkinson's Disease Dementia (R01 Clinical Trial Not Allowed) |
NIH |
03/05/2019 |
05/07/2022 |
|
|
NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional) |
NIH |
12/26/2018 |
10/06/2021 |
|
|
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional) |
NIH |
12/21/2018 |
01/07/2022 |
|
|
Mentored Quantitative Research Development Award (Parent K25 - Independent Clinical Trial Required) |
NIH |
12/20/2018 |
01/07/2022 |
|
|
Mentored Quantitative Research Development Award (Parent K25 - Independent Clinical Trial Not Allowed) |
NIH |
12/20/2018 |
01/07/2022 |
|
|
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed) |
NIH |
12/17/2018 |
01/07/2022 |
|
|
Control of Sexually Transmitted Infections (STIs) Through a Comprehensive Understanding of the Natural History of Infection (R01 Clinical Trial Not Allowed) |
NIH |
11/29/2018 |
01/07/2022 |
|
|
Mentored Quantitative Research Development Award (Parent K25 - Independent Basic Experimental Studies with Humans Required) |
NIH |
11/28/2018 |
01/07/2022 |
|
|
Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed) |
NIH |
11/26/2018 |
01/07/2022 |
|
|
Molecular and Genetic Characterization of Inborn Errors of Immunity (R21 Clinical Trial Not Allowed) |
NIH |
11/26/2018 |
01/07/2022 |
|
|
Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed) |
NIH |
11/26/2018 |
01/07/2022 |
|
|
Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R01 Clinical Trial Not Allowed) |
NIH |
11/26/2018 |
01/07/2022 |
|
|
Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R21 Clinical Trial Not Allowed) |
NIH |
11/26/2018 |
01/07/2022 |
|
|
Telomeres in Wellness and Disease: A Biobehavioral Approach (R21 Clinical Trial Optional) |
NIH |
11/20/2018 |
01/07/2022 |
|
|
Telomeres in Wellness and Disease: A Biobehavioral Approach (R01 Clinical Trial Optional) |
NIH |
11/20/2018 |
01/07/2022 |
|
|
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) |
NIH |
11/16/2018 |
11/12/2021 |
|
|
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed) |
NIH |
11/16/2018 |
11/12/2021 |
|
|
Processing and Presentation of Non-Conventional MHC Ligands (R01 Clinical Trial Not Allowed) |
NIH |
11/13/2018 |
01/07/2022 |
|
|
Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed) |
NIH |
11/13/2018 |
01/07/2022 |
|
|
Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Clinical Trial Not Allowed) |
NIH |
11/13/2018 |
01/07/2022 |